Treatment of dyslipidaemia in HIV-infected persons.

about

Ritonavir increases CD36, ABCA1 and CYP27 expression in THP-1 macrophages.

P2860

Q39930180-1E92378F-B358-4E1A-A8B5-7F16242886B0

P2860

Treatment of dyslipidaemia in HIV-infected persons.

Item

http://www.wikidata.org/entity/Q36222023

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Treatment of dyslipidaemia in HIV-infected persons.

@ast

Treatment of dyslipidaemia in HIV-infected persons.

@en

type

Item

label

Treatment of dyslipidaemia in HIV-infected persons.

@ast

Treatment of dyslipidaemia in HIV-infected persons.

@en

prefLabel

Treatment of dyslipidaemia in HIV-infected persons.

@ast

Treatment of dyslipidaemia in HIV-infected persons.

@en

P1476

Treatment of dyslipidaemia in HIV-infected persons.

@en

P2093

Philip E Tarr

http://www.w3.org/2001/XMLSchema#string

Rodolphe Thiébaut

http://www.w3.org/2001/XMLSchema#string

Roger Darioli

http://www.w3.org/2001/XMLSchema#string

P2860

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.

Adverse effects of antiretroviral therapy.

Clinically relevant differences between the statins: implications for therapeutic selection.

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Antiretroviral therapy-associated hyperlipidaemia in HIV disease.

P304

1619-1645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.6.10.1619

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Oriol Manuel

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16086650

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias

Treatment of dyslipidaemia in HIV-infected persons.

about

P2860

P2860

Treatment of dyslipidaemia in HIV-infected persons.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921